S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ACRS Aclaris Therapeutics Inc

2.48

0.00 (0.00%)

Dec 31 2024 - Closed

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Aclaris Therapeutics Charts.

Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Aclaris Therapeutics Charts.

Aclaris Therapeutics Inc News

Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 31 December 2024 (1 day ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Thursday 19 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 12 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 6 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form D - Notice of Exempt Offering of Securities
Wednesday 4 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 3 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Tuesday 3 December 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 3 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 27 November 2024 (1 month ago) • Edgar (US Regulatory)

Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
Tuesday 26 November 2024 (1 month ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Monday 25 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 22 November 2024 (1 month ago) • Edgar (US Regulatory)

More Aclaris Therapeutics Inc News Articles

Moon Equity (PK)

Accredited Solutions (PK)

Anavex Life Sciences

Digital Brand Media and ... (PK)

Kraig Biocraft Laborator... (QB)

Lightwave Logic

North Bay Resources (PK)

Fannie Mae (QB)

Code Green Apparel (PK)

Intergrated Cannabis Sol... (PK)

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions